Cargando…
Evaluation of confirmatory data following the Article 12 MRL review for paclobutrazol
The applicant Proplan Plant Protection Company submitted a request to the competent national authority in Austria (originally the United Kingdom) to evaluate the confirmatory data that were identified for paclobutrazol in the framework of the MRL review under Article 12 of Regulation (EC) No 396/200...
Autores principales: | Bellisai, Giulia, Bernasconi, Giovanni, Brancato, Alba, Cabrera, Luis Carrasco, Castellan, Irene, Del Aguila, Monica, Ferreira, Lucien, Santonja, German Giner, Greco, Luna, Jarrah, Samira, Leuschner, Renata, Magrans, Jose Oriol, Miron, Ileana, Nave, Stefanie, Pedersen, Ragnor, Reich, Hermine, Robinson, Tobin, Ruocco, Silvia, Santos, Miguel, Scarlato, Alessia Pia, Theobald, Anne, Verani, Alessia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677324/ https://www.ncbi.nlm.nih.gov/pubmed/36419560 http://dx.doi.org/10.2903/j.efsa.2022.7651 |
Ejemplares similares
-
Evaluation of confirmatory data following the Article 12 MRL review for tebufenpyrad
por: Bellisai, Giulia, et al.
Publicado: (2023) -
Evaluation of confirmatory data following the Article 12 MRL review for thiabendazole
por: Bellisai, Giulia, et al.
Publicado: (2022) -
Evaluation of confirmatory data following the Article 12 MRL review for fenbuconazole
por: Bellisai, Giulia, et al.
Publicado: (2023) -
Evaluation of confirmatory data following the Article 12 MRL review for S‐metolachlor
por: Bellisai, Giulia, et al.
Publicado: (2023) -
Evaluation of confirmatory data following the Article 12 MRL review for napropamide
por: Bellisai, Giulia, et al.
Publicado: (2023)